logo
  

Medtronic In Deal With BioIntelliSense For U.S. Distribution Rights Of BioButton Wearable

Irish healthcare technology company Medtronic plc (MDT) announced Wednesday it has entered into a strategic partnership with BioIntelliSense for exclusive U.S. distribution rights of the BioButton multi-parameter wearable for remote patient monitoring from in-hospital to home. Terms of the deal were not disclosed.

As per the deal, BioIntelliSense, a continuous health monitoring and clinical intelligence company, will offer exclusive U.S. hospital and 30-day post-acute hospital to home distribution rights of the BioButton.

BioButton wearable offers up to 1,440 vital signs measurements daily, monitoring patients transitioning from higher to lower acuity settings.

Medtronic said the technology complements its Patient Monitoring business' HealthCast intelligent patient manager portfolio designed for connectivity, visualization, remote patient monitoring, and now, wearables.

According to the company, the Patient Monitoring business intends to continue to expand its HealthCast portfolio to improve workflow automation, with staffing shortages projected to reach 3.2 million healthcare workers by 2026.

The HealthCast connectivity gateway helps increase workflow efficiency by connecting unconnected devices to the electronic medical records.

James Mault, founder and CEO of BioIntelliSense, said, "In partnership with Medtronic, we are poised to accelerate continuous connected care models that offer a new level of clinical surveillance and workflow efficiencies for hospitals that are challenged in today's environment of growing workforce shortages and cost of care management. This advanced remote physiologic monitoring simplifies care delivery to facilitate personalized patient care, clinical workflow automation and proactive clinical interventions."

For More Such Health News, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lenoir, North Carolina -based Exela Pharma Sciences, LLC has expanded its recall of Sodium Bicarbonate Injection due to vial breakage to include more lots, the U.S. Food and Drug Administration said. The product is used for treatment of metabolic acidosis and is packaged in a 50 mL glass vial, 20 vials per carton. Elon Musk, who recently took Twitter Inc. private in a $44-billion deal, accused Apple Inc. of threatening to block the social media platform from its app store without giving the reason. In a series of tweets on Monday, the Tesla founder and CEO also said the tech giant had stopped advertising on Twitter, and that it was pressuring the firm over content moderation demands. Payments platform Paysafe has inked a partnership deal with Richard Branson's Virgin Voyages to enable travelers to speedily and securely make online payments for reserving next cruise booking. Paysafe's travel solution will also help mitigate all payment risks for travelers.
Follow RTT